New iPLEDGE Rules: What’s Changing for Isotretinoin Rxs
October 2026
You’ll see updates to the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) for isotretinoin Rxs starting November 15, 2026.
Pharmacies must still get a Risk Management Authorization (RMA) from the iPLEDGE website before dispensing isotretinoin...to verify that prescribers and patients are registered and requirements to prevent pregnancy are met.
But look for several iPLEDGE requirements to be rolled back...to try to ease the burden on patients and clinicians while maintaining safe use.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote